Image

Death Anxiety, Depression and Anxiety: An Experimental Study

Death Anxiety, Depression and Anxiety: An Experimental Study

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

The goal of this experimental study is to investigate the transdiagnostic role of death anxiety in depression and anxiety symptoms in participants from the general population.

The main questions it aims to answer are:

  1. Does the mortality salience task induce death anxiety?
  2. Does the experimental group present an increase in depression and anxiety symptoms following the mortality salience task?

The investigators will compare the experimental condition to a control condition to see if the death anxiety induction is responsible for the expected increase in depression and anxiety symptoms.

The mortality salience prompt will be asking participants to elaborate on their thoughts and feelings surrounding death and dying, including what they think happens during death. The dental pain prompt will ask participants to do the same, only in regards to the thought of having dental pain.

Experimental group: participants will undergo a pen-and-paper writing task where they will be asked to answer two questions:

  1. "Please briefly describe the emotions that the thought of your own death arouses in you."
  2. "Jot down, as specifically as you can, what you think will happen to you physically as you die and once you are physically dead."

Control group:

  1. "Please briefly describe the emotions that the thought of dental pain arouses in you."
  2. "Jot down, as specifically as you can, what you think happens to you physically as you experience dental pain and once you have physically experienced dental pain."

Description

The purpose of this study is to investigate the role of death anxiety as a transdiagnostic factor in psychopathology. In this particular study, the investigators will examine whether increases in death anxiety - brought about by increasing the salience of death by use of a mortality salience prime lead to increases in levels of depression and anxiety.

Participants will provide their informed consent and will proceed to complete the measures of the study (pretest). Eligible participants will be randomly allocated to either the mortality salience group (experimental group), or the dental pain group (the control group). Participants will be blind to group allocation.

Two weeks after completing the pretest measures, the participants will come to the lab and undergo the experimental tasks, depending on the condition that they have been allocated to.

Experimental group: participants will undergo a pen-and-paper writing task where they will be asked to answer two questions

  1. Please briefly describe the emotions that the thought of your own death arouses in you.
  2. Jot down, as specifically as you can, what you think will happen to you physically as you die and once you are physically dead.

Control group: participants will undergo a pen-and-paper writing task where they will be asked to answer two questions

  1. Please briefly describe the emotions that the thought of dental pain arouses in you.
  2. Jot down, as specifically as you can, what you think happens to you physically as you experience dental pain and once you have physically experienced dental pain.

After the prime, participants will complete a distractor task, during which they will be asked to read a short, emotionally neutral text - a bogus scientific article, estimated to be a 5 minute read - and answer questions based on this text. Participants will be told that this task is done in order to assess text comprehension abilities. After completing the distractor task, participants will complete the study measures the second time (posttest).

Upon study completion, all participants will be debriefed in the lab, and the real purpose of the study will be explained to them.

Eligibility

Inclusion Criteria:

  • Age over 18 years.
  • Living in Cluj-Napoca (or otherwise willing and able to participate in the lab task)

Exclusion Criteria:

  • Personality disorder diagnosis
  • Psychotic disorder diagnosis
  • Suicidal ideation

Study details
    Death Anxiety
    Depression
    Anxiety

NCT07201480

Babes-Bolyai University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.